Results 121 to 130 of about 3,561 (181)

Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors

open access: yes, 2007
Integrase is actively studied as an antiviral target, but many inhibitors selected from biochemical screens fail to inhibit human immunodeficiency virus (HIV) replication or primarily affect off-site targets.
De Clercq, Erik   +3 more
core   +1 more source

A Natural LTR Retrotransposon Insertion in the Promoter of GhNAC140‐Dt Boosts Cotton Lint Yield

open access: yesPlant Biotechnology Journal, Volume 24, Issue 6, Page 4240-4262, June 2026.
ABSTRACT Transposable elements (TEs) are fundamental drivers of crop evolution and domestication. Whereas the underlying mechanisms of TE‐mediated gene activation remain poorly understood. Lint percentage is an important yield component in cotton. Here, we report a retrotransposon insertion in the promoter of GhNAC140‐Dt, a secondary wall NAC encoding ...
Yujia Yu   +9 more
wiley   +1 more source

Role of Integrase Acetylation in HIV-1 Replication Cycle and Search for Acetylation Inhibitors [PDF]

open access: yes, 2013
HIV-1 integrase catalyzes the integration of the viral DNA into the genome of the host cells. This irreversible event is crucial to the pathogenesis of the infection and complicates its eradication both by the immune systems and by pharmacological ...
VALENTINI, PAOLA
core  

Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.

open access: yes, 2004
International audienceWe have previously shown that styrylquinolines (SQLs) are integrase inhibitors in vitro. They compete with the long terminal repeat substrate for integrase. Here, we describe the cellular mode of action of these molecules.
Vita, Claudio   +9 more
core   +1 more source

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS

open access: yesHIV/AIDS: Research and Palliative Care, 2014
Krishan K PandeyInstitute for Molecular Virology, Saint Louis University Health Sciences Center, St Louis, MO, USAAbstract: Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency
Pandey KK
doaj  

Caffeoylquinic acids as inhibitors for HIV-I protease and HIV-I integrase: a molecular docking study [PDF]

open access: yes, 2016
Caffeoylquinic acids are ubiquitous phenolic compounds with several health benefits to humans and they have been shown to be promisinganti-HIV compounds.
Castilho, Paula C.   +2 more
core  

Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors

open access: yes, 2016
Using a training set of diketo-like acid HIV-1 integrase (IN) strand-transfer inhibitors, a 3D pharmacophore model was derived having quantitative predictive ability in terms of activity.
Alba Chimirri (76729)   +8 more
core   +1 more source

Inhibitors of HIV-1 integrase from Dioscorea bulbifera [PDF]

open access: yesSongklanakarin Journal of Science and Technology (SJST), 2016
A search for HIV-1 integrase (IN) inhibitors from natural sources has led to the isolation of compounds from Dioscorea bulbifera bulbils. From the bioassay-guided isolation, the chloroform fraction was then fractionated to obtain one new clerodane ...
Prapaporn Chaniad   +3 more
doaj  

4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in Cells

open access: yes, 2016
4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in ...
Lori J. Gabryelski (3010656)   +20 more
core   +1 more source

Ruthenium arene complexes as HIV-1 integrase strand transfer inhibitors

open access: yes, 2013
The quinolone HL1 and the hydroxypyrimidine-carboxamide HL2 were designed and synthesized as models of the HIV integrase strand transfer inhibitors Elvitegravir and Raltegravir (brand name Isentress), with the aim to study their complexing behavior and ...
Bacchi, Alessia   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy